Andreas Lundqvist

Best Publications

• Cancer classification using the Immunoscore: a worldwide task force

  Jérôme Galon;Franck Pagès;Francesco M Marincola;Francesco M Marincola;Helen K Angell;Helen K Angell

  961
  Citations

• Heat-shock proteins as activators of the innate immune system

  Robert P.A Wallin;Andreas Lundqvist;Solveig H Moré;Arne von Bonin

  766
  Citations

• Inhibition of Tumor-Derived Prostaglandin-E2 Blocks the Induction of Myeloid-Derived Suppressor Cells and Recovers Natural Killer Cell Activity

  Yumeng Mao;Dhifaf Sarhan;André Steven;Barbara Seliger

  302
  Citations

• Clinical-grade ex vivo-expanded human natural killer cells up-regulate activating receptors and death receptor ligands and have enhanced cytolytic activity against tumor cells

  Maria Berg;Andreas Lundqvist;Philip McCoy;Leigh Samsel

  289
  Citations

• Regression of human kidney cancer following allogeneic stem cell transplantation is associated with recognition of an HERV-E antigen by T cells.

  Yoshiyuki Takahashi;Nanae Harashima;Sachiko Kajigaya;Hisayuki Yokoyama

  225
  Citations

• A phase I trial of DNA vaccination with a plasmid expressing prostate-specific antigen in patients with hormone-refractory prostate cancer

  M. Pavlenko;A.-K. Roos;A. Lundqvist;A. Palmborg

  223
  Citations

• CXCL10-induced migration of adoptively transferred human natural killer cells toward solid tumors causes regression of tumor growth in vivo

  Erik Wennerberg;Veronika Kremer;Richard Childs;Andreas Lundqvist

  210
  Citations

• The Role of CXC Chemokine Receptors 1–4 on Immune Cells in the Tumor Microenvironment

  Unknown

  207
  Citations

• NK cells and solid tumors: therapeutic potential and persisting obstacles

  Unknown

  204
  Citations

• Melanoma-Educated CD14+ Cells Acquire a Myeloid-Derived Suppressor Cell Phenotype through COX-2–Dependent Mechanisms

  Yumeng Mao;Isabel Poschke;Erik Wennerberg;Yago Pico de Coaña

  198
  Citations

• CD73 immune checkpoint defines regulatory NK cells within the tumor microenvironment

  Shi Yong Neo;Ying Yang;Ying Yang;Julien Record;Ran Ma

  196
  Citations

• IL-15 activates mTOR and primes stress-activated gene expression leading to prolonged antitumor capacity of NK cells.

  Yumeng Mao;Vincent van Hoef;Xiaonan Zhang;Xiaonan Zhang;Erik Wennerberg

  174
  Citations

• Bortezomib and Depsipeptide Sensitize Tumors to Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand: A Novel Method to Potentiate Natural Killer Cell Tumor Cytotoxicity

  Andreas Lundqvist;Scott I. Abrams;David S. Schrump;Gauri Alvarez

  173
  Citations

• Regression of human kidney cancer following allogeneic stem cell transplantation is associated with recognition of an HERV-E antigen by T cells

  Unknown

  171
  Citations

• Immunomodulatory Effects of IL-2 and IL-15; Implications for Cancer Immunotherapy

  Unknown

  167
  Citations

• Genetic engineering of human NK cells to express CXCR2 improves migration to renal cell carcinoma

  Unknown

  161
  Citations

• Tissue distribution and differential expression of melanocortin 1 receptor, a malignant melanoma marker.

  Salazar-Onfray F;López M;Lundqvist A;Aguirre A

  156
  Citations

• Ipilimumab treatment decreases monocytic MDSCs and increases CD8 effector memory T cells in long-term survivors with advanced melanoma.

  Yago Pico de Coana;Maria Wolodarski;Maria Wolodarski;Isabel Poschke;Yuya Yoshimoto

  153
  Citations

• Persistence of recipient plasma cells and anti-donor isohaemagglutinins in patients with delayed donor erythropoiesis after major ABO incompatible non-myeloablative haematopoietic cell transplantation.

  L. M. Griffith;J. P. McCoy;C. D. Bolan;D. F. Stroncek

  146
  Citations

• Overcoming graft rejection in heavily transfused and allo-immunised patients with bone marrow failure syndromes using fludarabine-based haematopoietic cell transplantation

  Ramaprasad Srinivasan;Yoshiyuki Takahashi;J. Philip McCoy;Igor Espinoza-Delgado

  139
  Citations